Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
2.81
-0.08 (-2.77%)
At close: May 23, 2025, 3:59 PM
2.82
0.53%
After-hours: May 23, 2025, 05:57 PM EDT
-2.77% (1D)
| Bid | 2.75 |
| Market Cap | 217.43M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -139.68M |
| EPS (ttm) | -3.01 |
| PE Ratio (ttm) | -0.93 |
| Forward PE | -1.29 |
| Analyst | Buy |
| Ask | 2.92 |
| Volume | 777,453 |
| Avg. Volume (20D) | 1,489,957 |
| Open | 2.81 |
| Previous Close | 2.89 |
| Day's Range | 2.73 - 2.82 |
| 52-Week Range | 2.41 - 10.37 |
| Beta | 2.33 |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-20.33%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
3 months ago
+22.08%
Solid Biosciences shares are trading higher after Chardan Capital maintained a Buy rating on the stock and raised its price target from $15 to $16.
